By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BrainStorm Cell Therapeutics Inc. 



Tel Aviv      Israel
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
BrainStorm Cell Seeking Approval To Distribute NurOwn In Canada 2/21/2017 7:25:43 AM
City of Hope To Manufacture NurOwn For BrainStorm Cell's Phase III ALS Clinical Trial 2/16/2017 7:24:32 AM
BrainStorm Cell Announces Validation Of NurOwn Cryopreservation Process 1/30/2017 8:17:43 AM
BrainStorm Cell Reports On Successful End Of Phase 2 Meeting With FDA, Upcoming Phase 3 Trial And Planned Application For Hospital Exemption For NurOwn 12/19/2016 8:28:44 AM
BrainStorm Cell Release: In-Depth Analyses Presented At International Symposium On ALS/MND Suggest Strong Biological Effect For NurOwn; Evidence Of Halting Of Disease Progression 12/14/2016 6:55:48 AM
BrainStorm Cell Reports Third Quarter 2016 Financial Results 11/15/2016 10:50:46 AM
BrainStorm Cell Granted United States Patent For Its Stem Cell Technology 10/31/2016 6:52:30 AM
BrainStorm Cell CEO To Present At Two Investor Conferences In September 9/6/2016 1:11:46 PM
BrainStorm Cell Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/11/2016 9:52:51 AM
BrainStorm Cell Announces Positive Top Line Results From The U.S. Phase 2 Study Of NurOwn In Patients With Amyotrophic Lateral Sclerosis (ALS) 7/18/2016 7:35:01 AM
12345678910...
//-->